We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS and FEMA will control the distribution of Gilead’s remdesivir as a COVID-19 treatment as a condition of its Emergency Use Authorization (EUA) by the FDA. Read More
Moderna has signed a 10-year agreement with Swiss manufacturer Lonza to manufacture its COVID-19 vaccine candidate and other future products. Read More
Gilead announced that it has 1.5 million individual doses of its antiviral remdesivir available for use as a COVID-19 treatment and will donate the doses when they’re needed. Read More
Vertex Pharmaceuticals’ cystic fibrosis drug Trikafta (elexacaftor/tezacaftor/ivacaftor) will need a dramatic price cut to be cost effective, the Institute for Clinical and Economic Review (ICER) found in a new analysis. Read More